HC Wainwright & Co. Upgrades Cassava Sciences to Buy, Announces $116 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has upgraded Cassava Sciences (NASDAQ:SAVA) from Neutral to Buy, setting a price target of $116. This upgrade reflects a positive outlook on the company's stock.
October 08, 2024 | 12:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has upgraded Cassava Sciences from Neutral to Buy, with a new price target of $116. This suggests a positive outlook and potential for stock price appreciation.
The upgrade from Neutral to Buy by a reputable analyst firm like HC Wainwright & Co. typically indicates increased confidence in the company's future performance. The $116 price target suggests significant upside potential from current levels, likely leading to positive investor sentiment and potential stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100